TIL

Instil Bio, Inc.

$6.35

-1.85%
SectorHealthcareIndustryBiotechnologyCountryUnited States

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

Source: Yahoo Finance
AI summary

Price & performance

1M+0.6%
3M-3.7%
YTD-38.0%
1Y-54.7%
52-week range—
Beta1.72
Full chart and returns against a benchmark

Q-Score

52/ 100

Quality against peers; 50 is the peer median.

Growth44
Risk40
Performance56
Valuation52
Profitability56
Leverage62
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue—
Net income-$71.4M
Net margin—
Historical fundamentals

Red flags in filings

1active red flag
Auditor changeApr 3, 2026
Filings, findings and the timeline

Revenue exposure

Regions, segments, customers and suppliers

Valuation

TILIndustryP/E—89.69P/S—11.88EV/EBITDA—67.10P/B0.406.22PEG—4.02
Dividend yield0.00%
Every valuation metric